Genolution Inc. (KOSDAQ:225220)
South Korea
· Delayed Price · Currency is KRW 1,663.00
-36.00 (-2.12%)
At close: Mar 6, 2026
Genolution Company Description
Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally.
Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology.
The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits.
It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/shRNA synthesis service and related products.
Genolution Inc. was founded in 2006 and is based in Seoul, South Korea.
Genolution Inc.
| Country | South Korea |
| Founded | 2006 |
| Industry | Surgical and Medical Instruments and Apparatus |
| Employees | 75 |
| CEO | Ki-Ok Kim |
Contact Details
Address: 63 Magokjungang 8-ro 3-gil Seoul, 05836 South Korea | |
| Phone | 82 2 449 8670 |
| Website | genolution.co.kr |
Stock Details
| Ticker Symbol | 225220 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Ki-Ok Kim | Chief Executive Officer |
| Sanghun Kim | Chief Financial Officer |